Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Aurora Cannabis Stock Holders Continue to Suffer Huge Goodwill Effects

Aurora Cannabis stock holders continue to suffer and this probably won't change anytime soon as the company faces numerous challenges.

Why You Should Wait to Buy Marijuana Stocks

I was recently asked if investors should buy marijuana stocks now or wait until we see profits. My answer? Wait. Here's why.

Canopy Growth Can Exonerate Vaping Industry

Investors may be tempted to dump CGC stock over Canopy’s vaping ambitions, but this could be an educational opportunity.

Akerna Earnings: KERN Stock Up 18% on 2019 Earnings

Akerna (KERN) earnings for the marijuana-tracking company's fiscal full year of 2019 has KERN stock soaring after hours Monday.

Battered Canopy Growth Stock Could Reach New Lows

CGC stock continues to face hurdles. With shares still overvalued, look elsewhere for pot stock opportunity.

3 Reasons Canopy Growth Stock Should Be a Long-Term Winner

CGC stock is poised to be a long-term winners thanks to deals with Constellation Brands and its acquisition of Acreage Holdings.

Capture the Cannabis Market Momentum with Canopy Growth Stock

We could be witnessing the start of a powerful comeback in CGC stock. Add Canopy Growth to your portfolio to ride high on the cannabis wave.

Should You Believe the Long-Term Narrative for Tilray Stock?

Once a high-flying cannabis player, Tilray stock has floundered along with the rest of the industry. But having recently found a bottom, speculators may be tempted to bet on TLRY’s long shot but viable narratives.

Now Is Not the Time to Buy Cronos Stock

CRON stock looks unlikely to make any upward movement in the near term, making it a poor choice in the marijuana space right now.

Leadership Transition Issues Exacerbate to CGC Stock Woes

Canopy Growth continues to have issues with its leadership transition. Because of this the price of CGC stock has declined.

Buckle Up and Get Yourself Some Shares of Aurora Cannabis Stock

There's nothing like the smell of cheap cannabis stocks -- and it doesn't get much cheaper than Aurora Cannabis stock right now.

3 Cannabis Stocks to Buy Today

Don’t get smoked in cannabis stocks. Stick with the price charts and the right blend of profits, risk and common sense.

Avoid Aurora Cannabis Stock Until Investor Fears Subside

Aurora Cannabis stock is in a downtrend that it cannot shake off. Strong fourth-quarter revenue numbers failed to impress. What's next?

Canopy Growth Stock Faces Big Problems

Canopy Growth stock faces big problems. The company needs to reach $1 billion CAD in sales to break even, but is nowhere near that level.

Canopy Growth Stock Emerges as Top Pick

CGC stock still isn't a name fit for grandma's safety portfolio, but Canopy Growth may be moving back into a bullish mode.

The ‘Secret’ Ingredient Set to Send Marijuana Stocks Soaring

Marijuana companies are right now hitting the investing sweet spot. Here's why now is the time to buy.

InvestorPlace Roundup: Aphria Stock Needs Better Friends

While oil stocks garnered the bulk of attention from many investors, readers were also interested in marijuana stocks and Nio.

Hexo Stock Could Fall After Its Earnings Release

Hexo stock could fall after its fiscal Q4 earnings release. Investors should expect an accelerated burn rate now that Hexo owns Newstrike.

Here’s Why Aurora Cannabis Stock Stumbled

Nowadays, cannabis-related companies need credibility of the financial variety. This focus on the fundamentals has struck its latest victim, Aurora Cannabis stock.